Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,027 public trials 2,025 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

NCT05823571

Conditions: Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

NCT03672318

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Active, Not Recruiting

Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

NCT07176130

Conditions: Endophthalmitis, Eye Diseases, Eye Infections, +18 more
Locations: Singapore National Eye Centre Singapore

View Trial Details

Active, Not Recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT02159495

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

NCT02716233

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU Amiens, France

CHU Angers, France

CHRU Besançon, France

CHU Bordeaux, France

View all 28 locations

View Trial Details

Active, Not Recruiting

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

NCT04071457

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 842 locations

View Trial Details

Active, Not Recruiting

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

NCT04447716

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Integrated Actionable Aging Assessment for Cancer Patients Pilot

NCT05871008

Conditions: Bladder Cancer, Blood Protein Disorders, Breast Cancer, +49 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Active, Not Recruiting

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

NCT04497961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States

View Trial Details

Active, Not Recruiting

2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy

NCT03004287

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions